Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.
Journal: Neuro-oncology advances
Published: February 08, 2024
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 27, 2023
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
Journal: Annals of hematology
Published: August 10, 2023
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 06, 2020
A role for the androgen receptor in the treatment of male breast cancer.
Journal: Critical reviews in oncology/hematology
Published: April 10, 2015
TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.
Journal: Molecular cancer therapeutics
Published: May 25, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026